Search | IOVS | ARVO Journals

Showing 1 – 20 of 76

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

The Influence of Corticosteroids on Choroidal Endothelial Cells in Central Serous Chorioretinopathy

Rebecca Kaye; David R. G. Christensen; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4326. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Barney Reeves; Rebecca Evans; Simon P Harding; Andrew Lotery; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1214. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Preliminary results in 18 patients undergoing retinal gene therapy for X-linked retinitis pigmentosa with codon-optimized AAV8-RPGR

Robert E MacLaren; Janet L Davis; Ninel Gregori; Jasmina Cehajic-Kapetanovic; Byron L Lam; Andrew Lotery; Cristina Martinez-Fernandez dela Camara; Anika Nanda; Anna Paola Salvetti; Paulo Stanga; Kanmin Xue

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1329. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Oral human-equivalent L-DOPA/Carbidopa dosages administered during the postnatal critical period of neuroplasticity rescues retinal morphology and visual function in a mouse model of human albinism

Aida Sanchez-Bretano; Jennifer Ann Scott; Tutte Newall; Savannah Lynn; Helen Griffiths; Ahmed Salman; Andrew Lotery; J. Arjuna Ratnayaka; James Edward Self; Helena Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1393. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Aflibercept in the real world – an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Sajjad Mahmood; Irene Mary Stratton; Raj Mukherjee; James S Talks; Clare Bailey; Andrew Lotery; Shahram Kashani; Faruque Ghanchi; Salim Natha; Peter Henry Scanlon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2626. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

Irene Mary Stratton; Peter Henry Scanlon; James S Talks; Usha Chakravarthy; Raj Mukherjee; Faruque Ghanchi; Sajjad Mahmood; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2637. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Designing a clinical trial to evaluate the safety and efficacy of oral soraprazan in Stargardt Disease

Carel C B Hoyng; Andrew Lotery; Katarina Stingl; Camiel Boon; Maurizio Parodi; Patty Dhooge; Tobias Peters; Wolfgang Klein; Mario G Fsadni; Hans Müller; Oliver Jungmann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5704. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE

Jennifer Dewing; David R. G. Christensen; Heidi Hongisto; Jennifer Scott; Ben Jenkins; Angela Jane Cree; Heli Skottman; J. Arjuna Ratnayaka; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):424. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Characterization of the retinal phenotype of the C57BL/6-c2J mouse model of human oculocutaneous albinism: implications for treatment development

Jennifer Ann Scott; Aida Sanchez-Bretano; Helen Griffiths; Jon Ward; Chiamaka Dibigbou; Flavie Soubigou; James Edward Self; Andrew Lotery; J. Arjuna Ratnayaka; Helena Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):529. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Proof of concept for oral Levodopa treatment in rescuing retinal morphology and visual function in a murine model of human albinism

Helena Lee; Jennifer Scott; Helen Griffiths; James Edward Self; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):530. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2019

Acceptability of OCT Angiography: A multicentre OCT Angiography NEtwork (OCTANE) study.

Faruque Ghanchi; Corinne Fulcher; Sobha Sivaprasad; Konstantinos Balaskas; Richard Peter Gale; Gabriella De Salvo; James S Talks; Andrew Lotery; Ian A Pearce

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3477. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Robert E MacLaren; Kanmin Xue; Alun R Barnard; Maria In?s Patrício; Thomas L Edwards; Susan Downes; Andrew Lotery; Graeme Black; Andrew Webster; Jasleen K Jolly; Miguel C Seabra

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1195. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Different patterns of anti-VEGF loading phase for diabetic macular edema (DME) treatment: data analysis from the UK Aflibercept Users Group.

Hussein Almuhtaseb; Irene Stratton; Peter Henry Scanlon; Andrew Lotery

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3608. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Subretinal Aβ injections induce a localised, early CNV phenotype in C57BL/6 mice

Savannah Lynn; Jennifer Scott; Helena helenalee100@yahoo.co.uk Lee; Roshni Desai; Tracey Newman; Angela Cree; Andrew Lotery; J. Arjuna Ratnayaka

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5827. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

A Multicentre Double-masked Randomised Controlled Non-Inferiority Trial comparing clinical and cost effectiveness of intravitreal therapy with ranibizumab (Lucentis) vs aflibercept (Eylea) vs bevacizumab (Avastin) for Macular Oedema due to Central Retinal Vein Occlusion [LEAVO]: Baseline patient sociodemographic and ocular characteristics.

Philip G Hykin; Joana Vasconcelas; Toby Prevost; Sobha Sivaprasad; Barry Hounsome; Usha Chakravarthy; Simon Harding; Andrew Lotery; Yit C. Yang; Piyali Sen; Jayashree Ramu; Luke Nicholson; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2569. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN ® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK

Fahd Quhill; Clare Bailey; Usha Chakravarthy; Andrew Lotery; Geeta Menon; James S Talks

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1906. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Lysosomal impairment in the Retinal Pigment Epithelium (RPE) - a pathway of damage in the ageing retina

Eloise Keeling; David A. Johnston; David S. Chatelet; David Tumbarello; Andrew Lotery; J. Arjuna Ratnayaka

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4487. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

In-silico prediction of novel splice altering variants in the myocilin gene in primary open angle glaucoma.

Angela Cree; Luke O'Gorman; Helen Griffiths; Andrew Lotery; Jane Gibson; Sarah Ennis

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5138. doi: https://doi.org/

ARVO Annual Meeting Abstract July 2018

Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab.

Holly Clarke; Anastasios Sepetis; Christina Rennie; Andrew Lotery; Debendra Sahu; Dario Inzerillo; Bhaskar Gupta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3606. doi: https://doi.org/

ARVO Annual Meeting Abstract June 2017

Long-term Outcome of Bevacizumab Therapy in Sorsby Fundus Dystrophy, A Case Series.

Rebecca Kaye; Andrew J Lotery

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):229. doi: https://doi.org/

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

The Influence of Corticosteroids on Choroidal Endothelial Cells in Central Serous Chorioretinopathy

Long-term clinical management of neovascular AMD and visual acuity outcome in IVAN trial participants

Preliminary results in 18 patients undergoing retinal gene therapy for X-linked retinitis pigmentosa with codon-optimized AAV8-RPGR

Oral human-equivalent L-DOPA/Carbidopa dosages administered during the postnatal critical period of neuroplasticity rescues retinal morphology and visual function in a mouse model of human albinism

Aflibercept in the real world – an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Aflibercept in the real world – are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

Designing a clinical trial to evaluate the safety and efficacy of oral soraprazan in Stargardt Disease

Modelling Sorsby’s Fundus Dystrophy using patient-derived iPSC-RPE

Characterization of the retinal phenotype of the C57BL/6-c2J mouse model of human oculocutaneous albinism: implications for treatment development

Proof of concept for oral Levodopa treatment in rescuing retinal morphology and visual function in a murine model of human albinism

Acceptability of OCT Angiography: A multicentre OCT Angiography NEtwork (OCTANE) study.

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Different patterns of anti-VEGF loading phase for diabetic macular edema (DME) treatment: data analysis from the UK Aflibercept Users Group.

Subretinal Aβ injections induce a localised, early CNV phenotype in C57BL/6 mice

United Kingdom multicenter Medisoft™ electronic medical record real-world audit following implant of ILUVIEN ® (fluocinolone acetonide 190 µg) – the first 3-year results from the UK

Lysosomal impairment in the Retinal Pigment Epithelium (RPE) - a pathway of damage in the ageing retina

In-silico prediction of novel splice altering variants in the myocilin gene in primary open angle glaucoma.

Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab.

Long-term Outcome of Bevacizumab Therapy in Sorsby Fundus Dystrophy, A Case Series.

To View More...

You must be signed into an individual account to use this feature.